Tales from the Heart
An inspiring, educational and informative collection of conversations with thought leaders, physicians, industry, and patients related to cardiac care. We will discuss living with heart disease, treating patients, legislative issues, drug development and more.
New Hope for Nonobstructive HCM
Lisa Salberg welcomes Dr. Marty Maron to discuss the latest breakthroughs in HCM care, including promising clinical trials and emerging treatments for nonobstructive HCM. They also explore why recognizing and reporting symptoms matters, challenges with insurance coverage and family screening, and key takeaways from the recent HCM Summit.
This conversation was recorded Nov. 13, 2026
HCM: Three Decades of Progress and Promise
Lisa Salberg reunites with longtime friend and HCM expert Professor Perry Elliott to reflect on more than 30 years of advances in diagnosis, treatment and research. They explore groundbreaking new therapies, the challenges of accessing specialized care and the promise of more personalized treatments that could change the future of HCM.
This conversation was recorded on Nov. 11, 2026
From HCM Patient to Heart Doctor
Lisa Salberg sits down with Dr. Colby Salerno to trace his remarkable journey from an HCM diagnosis at age 12 and heart transplant as a young adult to becoming a transplant cardiologist and HCM specialist. They explore life after transplant, advances in HCM care and why today’s patients have more reason for hope than ever before.
This conversation was recorded Oct. 16, 2026.
A New Era for Kids With HCM
Lisa Salberg and Dr. Joe Rossano explore a major milestone in pediatric HCM care: the expansion of mavacamten to children weighing 66 pounds or more. They break down the SCOUT-HCM results, safety and monitoring, and the exciting possibility that treating HCM earlier could change the course of the disease over a lifetime.
This conversation was recorded October 5, 2026.
Getting to the Heart of Diagnosis
Lisa Salberg welcomes Dr. Sabahat Bokhari to celebrate the launch of a new HCMA Recognized Center of Excellence at Robert Wood Johnson University Hospital. They discuss why accurately diagnosing the cause of a thickened heart matters and how imaging, genetics and a multidisciplinary team can help patients find the right path to personalized care.
This conversation was recorded October 2, 2026
A Different Approach to the HCM Heart
Lisa Salberg talks with Jasmine Patel, Dr. Michael Ayers and Alan Russell of Edgewise Therapeutics about the science behind EDG-7500 and its unique mechanism of action. They break down how this investigational therapy is designed to fine-tune heart contraction and improve relaxation, and what researchers hope it could mean for people with HCM.
This conversation was recorded October 1, 2026
When AFib Meets HCM
Lisa Salberg and Dr. Alex de Feria take a closer look at atrial fibrillation in people with HCM, from recognizing symptoms and reducing stroke risk to medications, cardioversion and newer ablation techniques. They also discuss the rapidly expanding HCM treatment toolbox and why specialized care matters.
This conversation was recorded September 24, 2026
A New Era of Hope in HCM
Lisa Salberg is joined by HCMA Ambassadors Debra Rafson and Joey Graham to explore an exciting new era in HCM, from expanding clinical trials and treatment options to the new Hearts and Minds Mental Health Network. They also share why connection, community and the upcoming HCMA Annual Meeting matter so much to people living with HCM.
This conversation was recorded September 18, 2026.
What Longer Monitoring Reveals in HCM
Lisa Salberg and Dr. Martin Maron explore how extended heart monitoring is uncovering arrhythmias that may go undetected during traditional short-term monitoring. They also discuss A-Fib, today’s options for treating obstruction and emerging research targeting fibrosis in HCM.
Conversation recorded Sept. 11, 2026
A New HCM Treatment Takes Shape
Lisa Salberg and Dr. Anjali Owens break down promising new clinical trial results for EDG-7500, an investigational therapy for both obstructive and nonobstructive HCM. They explain how the drug may improve symptoms and heart relaxation while potentially offering a different safety and monitoring profile from current targeted therapies.
Conversation recorded Sept. 4, 2026.
Staying Ahead of AFib in HCM
Lisa Salberg and Dr. Harry Lever explore atrial fibrillation in HCM, from recognizing risk and monitoring heart rhythms to medications, cardioversion and evolving treatment options. They also discuss generic drug quality, emerging HCM therapies and how decades of progress are giving patients more tools than ever before.
Conversation was recorded on Sept. 4, 2026.
A Breakthrough for Nonobstructive HCM
Live from ESC in Munich, Lisa Salberg and Dr. Martin Maron unpack groundbreaking results from the ACACIA-HCM trial and what they could mean for people with nonobstructive HCM. They discuss improvements in symptoms and exercise capacity, potential changes in heart structure, and a possible path toward a long-awaited new treatment option.
Conversation was recorded Aug. 28, 2026
When HCM Symptoms Start to Change
Lisa Salberg and Dr. Michael Ayres discuss how patients and families can recognize changing HCM symptoms and know when to call their care team or seek urgent help. They also tackle back-to-school planning, beta blockers, cardiac scarring, autonomic symptoms and the changing HCM treatment toolbox.
Conversation recorded Aug. 21, 2026
Rethinking Beta Blockers in HCM
Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care.
This conversation was recorded Aug. 14, 2026
Expanding the HCM Treatment Toolbox
Lisa Salberg and Dr. Alex de Feria explore the growing HCM treatment toolbox, including the innovative SESAME procedure, emerging clinical trials and new possibilities for patients. They also tackle back-to-school planning, hydration, exercise, fatigue and helping children navigate life with HCM.
This conversation was recorded August 6, 2026.
Targeting Fibrosis: The Next HCM Frontier
Lisa Salberg and Dr. Martin Maron explore new directions in HCM care, including emerging therapies targeting cardiac fibrosis and what researchers are learning about scarring in the heart. They also look ahead to new clinical trial data and answer patient questions about imaging, arrhythmias and the future of HCM treatment.
This conversation was recorded July 24, 2026
The Generic Drug Wake-Up Call
Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system.
This conversation was recorded June 17, 2026.
Summer Strategies for Living Well
Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence.
This conversation was recorded June 19, 2026.
Surgery, Science and HCM Success
Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients.
This conversation was recorded June 8, 2026.
Building HCM Care in Alaska
Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving health equity, and what patients need to know about navigating care in remote communities.
This conversation was recorded June 5, 2026.
MRI Insights and HCM Risk
Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may improve risk prediction and help shape the future of personalized HCM care.
This conversation was recorded on May 29, 2026
HCM Breakthroughs and Tough Questions
Lisa Salberg and Dr. Alex de Feria explore the latest developments in HCM care, from promising non-obstructive HCM therapies to the challenges of recognizing symptoms, managing medications, and assessing sudden cardiac death risk. They also discuss clinical trials, fibrosis research, and why the future of HCM treatment has never looked brighter.
This conversation was recorded May 28, 2026.
Expanding Access to HCM Expertise
Host Lisa Salberg talks with Dr. Ronald H. Wharton about building a nationally recognized HCM Center of Excellence at Northwell Health on Long Island. They discuss patient education, new myosin inhibitor therapies, clinical trials, and why specialized HCM care can change lives for patients and families.
This conversation was recorded 5/21/26
The Pulse Behind HCM
Lisa Salberg welcomes Steven Kelley and Matt Grant to discuss HCMA’s new discussion group for men 40-ish and under living with HCM. The conversation explores friendship, mental health, dating, devices, and building a supportive space where younger men can openly share their experiences and connect with others facing similar challenges.
This conversation was recorded May 15, 2026.
The Future of HCM Care
Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy.
This conversation was recorded May 15, 2026.
New Directions in HCM Treatment
Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever.
This conversation was recorded May 8, 2026.
India’s Growing HCM Awareness Movement
Lisa Salberg welcomes Ram Khandelwal and Pallari Kamat for a global conversation about expanding HCM awareness and patient advocacy across India. The episode explores the challenges of diagnosis, healthcare access, and education while highlighting efforts to build stronger support systems for patients and families worldwide.
This conversation was recorded May 7, 2026.
SPECIAL REPORT: A Breakthrough for Non Obstructive HCM
Lisa Salberg and Dr. Marty Maron break down major new clinical trial results that could change treatment for patients with non obstructive HCM. They explain what the Acacia HCM trial found, why experts call it a transformative moment, and what the next steps could mean for patients around the world.
This conversation was recorded May 5, 2026.
HCM Treatment Shifts and New Therapies
Lisa Salberg and Dr. Matt Martinez break down how medical management for HCM is rapidly evolving, from traditional beta blockers to game-changing myosin inhibitors. They also preview what’s next, including emerging drugs, clinical trials, and new approaches that could reshape care in the near future.
This conversation was recorded May 1, 2026
Atrial Fibrillation Risk and New HCM Therapies
Lisa Salberg and Dr. Ethan Rowin break down new data on atrial fibrillation risk in patients taking myosin inhibitors for HCM. They explain what the latest research shows, how risk compares to traditional care, and what patients should watch for as treatment options continue to evolve.
This conversation was recorded April 28, 2026.
Understanding HCM Genetics Together
Lisa Salberg is joined by Lynda Neuhausen and Vi Tang to launch a new discussion group focused on the genetics of hypertrophic cardiomyopathy. They explore the science behind genetic testing, the emotional impact on families, and how open conversation can help patients navigate uncertainty and risk together.
This conversation was recorded April 24, 2026.
Honoring a Pioneer and HCM Progress
Lisa Salberg and Dr. Steve Ommen reflect on the legacy of a cardiology pioneer who helped shape modern HCM care, while discussing the latest in genetics, diagnosis, and treatment. They break down how far the field has come and what patients should understand as care continues to evolve.
This conversation was recorded April 24, 2026
Generic Drug Risks and Patient Safety
Lisa Salberg and Dr. Harry Lever take a hard look at generic drug quality and why consistency matters for people living with HCM. They break down real-world risks, what patients should watch for at the pharmacy, and how policy changes could improve safety nationwide.
This conversation was recorded April 17, 2026.
New Trial Targets Symptoms Beyond Obstruction
Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.
This conversation was recorded April 14, 2026
New Therapies and What Comes Next
Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.
This conversation was record April 10, 2026
Planning Ahead With HCM: What Matters Most
Lisa Salberg and Dr. Alex de Feria walk through how patients can stay proactive with hypertrophic cardiomyopathy—from annual testing and symptom tracking to understanding when to act. They break down real-world decision making, hidden symptoms, and how evolving care strategies can help patients stay ahead of their condition.
This conversation was recorded March 26, 2026.
Arrhythmias and Evolving HCM Treatment Strategies
Lisa Salberg and Dr. Marty Maron break down new research reshaping how HCM is treated, from long-standing beta blockers to emerging targeted therapies. They also walk through arrhythmia risks, monitoring, and prevention—giving patients a clearer roadmap for managing symptoms and long-term outcomes in a rapidly changing care landscape.
Conversation recorded March 13, 2026
Heart Health, Family History, and Action
Lisa Salberg sits down with Senator Anthony Bucco to discuss why Heart Month and knowing your family heart health history can save lives. They explore New Jersey’s leadership in cardiac screening laws, the importance of early detection for HCM, and ongoing efforts to improve insurance access and patient protections.
This conversation was recorded Feb. 20, 2026.
Awareness, Action and the Future of HCM
Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.
This conversation was recorded Feb. 20, 2026.
Living and Leading With HCM
Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.
This conversation was recorded Feb. 13, 2026